
Chelsea Lau, MD
Hematology Oncology
Highlights
Languages
- English
- Spanish
Gender
FemaleHospital Affiliation
- Good Samaritan Hospital
- Saint Joseph Hospital
About
About The Provider
Chelsea Lau, MD, is a board-certified hematologist-oncologist at Intermountain Health Cancer Center - Saint Joseph. Her clinical interests include breast cancer, genitourinary cancers, particularly prostate cancer, lung cancer, and benign and chronic blood disorders. She also enjoys evaluating complex hematologic diagnoses.
Dr. Lau is dedicated to providing compassionate, evidence-based care and values building strong relationships with her patients. By listening carefully and understanding each person's goals and priorities, she helps patients make informed decisions and navigate treatment with confidence.
Committed to delivering the highest standard of care, Dr. Lau stays current with advances in oncology and hematology to ensure patients receive the most effective treatment options available. She believes patients should play an active role in their care and works alongside them as a trusted partner throughout every stage of their journey.
Originally trained in Chicago, Dr. Lau recently relocated to Colorado and is excited to serve patients throughout the Denver area.
Outside of work, she enjoys spending time with her two young daughters, attending live theater, traveling, and exploring new cuisines.
Locations
- Intermountain Health Cancer Center - Saint Joseph
- 1818 North Ogden Street, Suite 200, Denver, CO 80218
- Get Directions
- Phone: 303-318-3434
- Fax: 303-318-3431
- Intermountain Health Cancer Center - Saint Joseph
- 1818 North Ogden Street, Suite 200, Denver, CO 80218
- Get Directions
- Phone: 303-318-3434
- Fax: 303-318-3431
Expertise
Education
- Fellowship: McGaw Medical Center of Northwestern University, Hematology & Oncology, 2026
- Residency: University of Virginia Health System, Internal Medicine, 2023
- Medical School: University of Virginia School of Medicine, 2019
Board Certifications
- Internal Medicine: American Board of Internal Medicine, 2022